Pharmacophore modeling is a sophisticated computational technique employed in drug design and discovery, revolutionizing the field by elucidating crucial interactions between drugs and their biological targets. At its core, pharmacophore modeling endeavors to identify and characterize the essential structural and chemical features of molecules that are vital for their biological activity. Through the meticulous analysis of ligand-receptor interactions, pharmacophore modeling provides invaluable insights into the molecular mechanisms underlying drug action, facilitating the rational design of novel therapeutics with enhanced efficacy and reduced side effects.
The process begins with the selection of a target protein or receptor, often implicated in disease pathways, followed by the identification of small molecule ligands with known bioactivity against the target. These ligands serve as the basis for constructing a pharmacophore model, wherein common structural motifs and functional groups critical for binding affinity and specificity are delineated. By aligning these pharmacophoric features, a three-dimensional representation of the ligand-receptor interaction profile is generated, offering a blueprint for the design of new compounds with optimized pharmacological properties.
Pharmacophore models can be refined iteratively through computational simulations and experimental validation, refining the predictive accuracy and utility of the model in guiding drug discovery efforts. The versatility of pharmacophore modeling extends beyond traditional drug design paradigms, encompassing applications in virtual screening, lead optimization, and scaffold hopping, thereby accelerating the pace of drug development and streamlining the identification of promising candidate molecules. Furthermore, pharmacophore modeling facilitates the exploration of structure-activity relationships (SARs), enabling medicinal chemists to rationalize the effects of molecular modifications on biological activity and potency. By leveraging advanced computational algorithms and molecular modeling techniques, pharmacophore modeling empowers researchers to navigate the complex landscape of chemical space, guiding the synthesis and evaluation of diverse chemical libraries to identify novel drug candidates with therapeutic potential.
Title : Advances in plasma-based waste treatment for sustainable communities
Hossam A Gabbar, Ontario Tech University, Canada
Title : Nanostructured biodevices based on carbon nanotubes and glyconanoparticles for bioelectrocatalytic applications
Serge Cosnier, Silesian University of Technology, Poland
Title : Carbon capture and storage: The impact of impurities in CO2 streams
Andy Brown, Progressive Energy Ltd, United Kingdom
Title : Supramolecular nano chemistries: Fighting viruses, inhibiting bacteria and growing tissues
Thomas J Webster, Hebei University of Technology, China
Title : Chemical engineering of vanadium and tantalum zeolites for application in environmental catalysis
Stanislaw Dzwigaj, Sorbonne Universite, France
Title : Disrupting TNF-α and TNFR1 interaction: Computational insights into the potential of D-Pinitol as an anti-inflammatory therapeutic
Ferran Acuna Pares, Universidad Internacional de la Rioja (UNIR), Spain